Login / Signup

Outcomes of Participants With Diabetes in the ISCHEMIA Trials.

Jonathan D NewmanRebecca AnthopolosG B John ManciniSubhash BanerjeeHarmony R ReynoldsDennis F KunichoffRoxy SeniorJesus PeteiroBalram BhargavaPallav GargJorge EscobedoRolf DoerrTomasz MazurekJose Gonzalez-JuanateyGrzegorz GajosCarlo BriguoriHong ChengAndras VertesSandeep MahajanLuis A GuzmanMatyas KeltaiAldo Pietro MaggioniGregg W StoneJeffrey S BergerYves D RosenbergWilliam E BodenBernard R ChaitmanJerome L FlegJudith S HochmanDavid J Maron
Published in: Circulation (2021)
Despite higher risk for death or MI, chronic coronary disease patients with diabetes did not derive incremental benefit from routine invasive management compared with initial medical therapy alone. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01471522.
Keyphrases
  • type diabetes
  • glycemic control
  • coronary artery disease
  • coronary artery
  • cardiovascular disease
  • healthcare
  • clinical practice
  • stem cells
  • mesenchymal stem cells
  • aortic stenosis
  • aortic valve